The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum]

• Main Authors: Walling DP (Author), Hassman HA (Author), Anta L (Author), Ochoa L (Author), Ayani I (Author), Martínez J (Author), Gutierro I (Author)
• Format: Book
• Published: Dove Medical Press, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Walling DP, Hassman HA, Anta L, et al. Drug Des Devel Ther. 2021;15:4371–4382. Page 4378, Table 2, PK Parameter column, the text “Cave (ng/nL)” should read “Cave (ng/mL)”. Page 4379, Table 3, PK Parameter column, the text “Cave (ng/nL)” should read “Cave (ng/mL)”. The authors apologize for the error...